The HPV vaccine: an analysis of the FUTURE II study
- PMID: 18077759
- PMCID: PMC2231560
The HPV vaccine: an analysis of the FUTURE II study
Comment on
- 
  
  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.N Engl J Med. 2007 May 10;356(19):1915-27. doi: 10.1056/NEJMoa061741. N Engl J Med. 2007. PMID: 17494925 Clinical Trial.
References
- 
    - Pitts M, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res. 2002;17(6):706–14. - PubMed
 
- 
    - Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health. 2005;37(6 Suppl):S17–23. - PubMed
 
- 
    - Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486–93. - PubMed
 
- 
    - Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, et al. Are women ready for the HPV vaccine? Gynecol Oncol. 2006;103(1):151–4. Epub 2006 March 21. - PubMed
 
- 
    - Zimet GD, Mays RM, Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis. 2000;27(1):49–52. - PubMed
 
Publication types
LinkOut - more resources
- Full Text Sources
 
        